FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: spastic paraplegia 31, autosomal dominant
Open Close
General Information
Name
spastic paraplegia 31, autosomal dominant
FlyBase ID
FBhh0001175
Disease Ontology Term
Parent Disease
Overview

This report describes spastic paraplegia 31, which shows autosomal dominant inheritance. The human gene implicated in this disease is REEP1, an ER protein required for correct formation of ER networks. There is a highest-ranking ortholog of human REEP1 in Drosophila, ReepA, although there are also two ReepA paralogs in Drosophila and six REEP family proteins in humans. Several alleles have been generated of ReepA, including amorphic alleles, fluorescently tagged alleles, and alleles carrying RNAi targeting constructs.

The human gene Hsap\REEP1 has been introduced into flies.

Overexpression of both human Hsap\REEP1 and fly ReepA cause a reduction in cisternal ER structures (ER sheets), whereas ReepA loss-of-function mutants show an increase in cisernal structures and reduction in tubular (peripheral) ER complexity. ReepA is upregulated in older flies and flies exposed to ER stress by heat-shock and tunicamycin treatment. ReepA mutant flies fail to trigger activations of aspects of the unfolded protein response to ER stress.

[updated Jan. 2020 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: spastic paraplegia
Symptoms and phenotype

The hereditary spastic paraplegias (SPG, HSP) are a large group of clinically and genetically diverse disorders characterized by progressive, usually severe, lower extremity spasticity and weakness. SPG is classified by mode of inheritance (autosomal dominant, autosomal recessive, and X-linked) and whether the primary symptoms occur in isolation ('uncomplicated SPG') or with other neurologic abnormalities ('complicated SPG'). [from MIM:182600; 15.06.29]

Specific Disease Summary: spastic paraplegia 31, autosomal dominant
OMIM report

[SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31](https://omim.org/entry/610250)

Human gene(s) implicated

[RECEPTOR EXPRESSION-ENHANCING PROTEIN 1; REEP1](https://omim.org/entry/609139)

Symptoms and phenotype

All SPG31 patients studied by Zuchner et al. 2016 (pubmed:16565863) had typical signs of spastic paraplegia mainly characterized by proximal weakness of the lower extremities with brisk reflexes and spastic gait abnormalities. The upper extremities showed normal tone and only very mild weakness of the small hand muscles. The sensory system was not involved. No additional neurologic symptoms were present that suggested cerebellar or visual involvement. Mutation in the REEP1 gene can also cause distal hereditary motor neuronopathy, type V (HMN5B; MIM:614751). Some patients with REEP1 mutations show overlapping signs of HMN5B and SPG31, indicating that there is a phenotypic spectrum of manifestations associated with REEP1 mutations. [adapted from MIM:610250, 2020.01.28]

Genetics

Hereditary spastic paraplegias have been associated with more than 40 different genetic loci, but well over 50% of HSP patients harbor pathogenic mutations in 1 of just 3 genes: spastin (SPG4, also known as SPAST), atlastin-1 (SPG3A, also known as ATL1), or receptor expression enhancing protein 1 (REEP1, also known as SPG31). (Adapted from Park et al. 2010, pubmed:20200447.)

At present, 56 pathogenic REEP1 variants have been reported. Disease-causing variants in REEP1 are predominantly truncating mutations suspected to trigger the nonsense-mediated mRNA decay, and the pathogenic mechanism is generally thought to be haploinsufficiency. A few pathogenic missense variants affecting highly conserved amino acids of REEP1 have been identified, as well, and 3′-UTR variants are speculated to be pathogenic by affecting a miRNA-binding site. (From Toft et al. 2019, pubmed:30637453.)

Beetz et al. 2008 (pubmed:18321925) postulate haploinsufficiency as the main molecular genetic mechanism of REEP1 pathogenesis. [adapted from MIM:610250, 2020.01.28]

Cellular phenotype and pathology
Molecular information

REEP1 modifies ER architecture, is implicated in ER stress response, and has a role in Lipid Droplet (LD) biogenesis. (Adapted from Napoli et al. 2019 and references therein, FBrf0244226.)

External links
Disease synonyms
SPG31
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to many: 3 human genes to 2 Drosophila genes.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Receptor expression enhancing protein A (ReepA) encodes a member of the DP1/Yop1p family. It localizes to the endoplasmic reticulum (ER) and is involved in the prevention of ER-stress. [Date last reviewed: 2019-03-14]
    Molecular function (GO)
    Gene Groups / Pathways
      Comments on ortholog(s)

      Drosophila genes ReepA and CG5539 are both high-ranking orthogs of human genes Hsap\REEP1, REEP2, and REEP3. In a 2014 publication (FBrf0226832), Appocher and colleagues concluded that ReepA was the closest ortholog of Hsap\REEP1.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (16 groups)
        RNA-protein
        Interacting group
        Assay
        References
        protein-protein
        Interacting group
        Assay
        References
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (6 alleles)
        Models Based on Experimental Evidence ( 0 )
        Allele
        Disease
        Evidence
        References
        Modifiers Based on Experimental Evidence ( 1 )
        Allele
        Disease
        Interaction
        References
        Models Based on Experimental Evidence ( 2 )
        Modifiers Based on Experimental Evidence ( 4 )
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        loss of function allele
        P-element activity
        amorphic allele - molecular evidence
        Delta2-3 transposase
        amorphic allele - molecular evidence
        Delta2-3 transposase
        References (9)